Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

On January 7, 2025, the U.S. Food and Drug Administration (“FDA” or “Agency”) released a long-awaited guidance titled, “Communications From Firms ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...

The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition labels ... illnesses by 2030. If approved and finalized, the proposal ...

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

(NYSE: NYSE:ZTS), a global leader in animal health with a market capitalization of $77.57 billion, has announced an immediate update to the U.S. label ... approved by the U.S. Food and Drug ...

The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...

If approved, it would give shoppers visible info on a food's saturated fat ... and industry advocates lobbied the FDA in 2023 to allow spices to bear the label "healthy" under its nutritional ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...